Telomir Pharmaceuticals (TELO) Stock Insights

TELO price $0.99 -0.03 -2.75%

Ticker
TELO
Price
$0.99
Change
-0.03 -2.75%
Market cap ?
$73.03M
Beta ?
-0.25
Sector
Healthcare
Industry
Biotechnology

Fair value

TELO fair value Not meaningful. Price $0.99.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare TELO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-02—-0.03—500.00K
2026-08-13-0.79-0.07——
2026-05-13-0.03-0.07——
2026-03-17-0.06-0.07——
2025-11-10-0.03-0.07——
2025-08-14-0.17-0.08——
2025-05-14-0.07-0.10——
2025-02-04-0.10-0.0518.79M—
2024-11-12-0.20-0.05——
2024-08-13-0.05———
2024-05-13-0.23———
2024-03-29-0.32———
2023-09-30-0.06———
2023-06-30-0.05———
2023-03-31-0.02———
2022-12-31-0.02———
2022-09-29-0.01———
2022-06-29-0.00———
2022-03-31-0.00———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-03Mushak AndriyOther0——
2026-05-21Aminov ErezBuy2.00M$1.302.60M
2026-05-21Aminov ErezBuy1.96M$1.302.55M
2026-05-21Aminov ErezSell1.96M$5.029.84M
2026-05-21Aminov ErezSell2.00M$2.104.20M
2026-05-21Whalen Matthew PrattBuy25.00K$1.3032.50K
2026-05-21Whalen Matthew PrattSell25.00K$5.02125.50K
2026-05-21MacPherson Edward CloustonBuy25.00K$1.3032.50K
2026-05-21MacPherson Edward CloustonSell25.00K$5.02125.50K
2026-05-21Del Giudice Matthew PaulBuy25.00K$1.3032.50K
2026-05-21Del Giudice Matthew PaulSell25.00K$5.02125.50K
2026-04-22Aminov ErezBuy7.32M$1.3710.03M
2026-04-16Whalen Matthew PrattBuy50.00K$1.3467.00K
2026-04-16MacPherson Edward CloustonBuy50.00K$1.3467.00K
2026-04-16Del Giudice Matthew PaulBuy50.00K$1.3467.00K
2025-09-29MIRA PHARMACEUTICALS, INC.Other0——
2025-05-28Aminov ErezBuy2.00M$2.104.20M
2025-05-28Aminov ErezBuy400.00K——
2025-05-15Weichselbaum AlanOther50.00K$2.75137.50K
2024-12-31Aminov ErezOther0——
2024-11-21Bay Shore TrustSell100.00K$3.73373.00K
2024-08-27Yanez MichelleBuy200.00K$5.021.00M
2024-08-27Jerman Michael AllenBuy25.00K$5.02125.50K
2024-08-27MacPherson Edward CloustonBuy25.00K$5.02125.50K
2024-08-27Aminov ErezBuy1.96M$5.029.84M
2024-08-27Del Giudice Matthew PaulBuy25.00K$5.02125.50K
2024-08-27Whalen Matthew PrattBuy25.00K$5.02125.50K
2024-08-19Aminov ErezSell200$6.011.20K
2024-08-19Aminov ErezSell200$6.201.24K
2024-08-08Del Giudice Matthew PaulOther0——
2024-08-08Whalen Matthew PrattOther0——
2024-08-08Aminov ErezOther0——
2024-08-08MacPherson Edward CloustonOther0——
2024-06-18Yanez MichelleOther0——
2024-02-13Bay Shore TrustBuy49.00K$7.00343.00K
2024-02-13Bay Shore TrustBuy49.00K$7.00343.00K
2024-02-13Bay Shore TrustBuy40.00K$7.00280.00K
2024-02-08Bay Shore TrustOther0——
2024-02-08Bay Shore TrustOther0——
2024-02-08Bay Shore TrustOther0——
2024-02-08Bay Shore TrustOther0——
2024-02-08Tuck TalhiaOther0——
2024-02-08Fuentes NathenOther0——
2024-02-08Jerman Michael AllenOther0——
2024-02-08McColl Hugh IIIOther0——
2024-02-08EAGLE CRAIGOther0——
2024-02-08Nicholoudis ChristosOther0——
2024-02-08Chapman Christopher C JROther0——
2024-02-08Kroenig BradleyOther0——
2023-06-15Bay Shore TrustOther2.44M$3.739.10M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 32, holders +5 vs prior quarter. Ownership 8.62%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC1.61M618.27K+62.11%2.07M
GEODE CAPITAL MANAGEMENT, LLC338.88K89.79K+36.05%433.91K
BLACKROCK, INC.280.47K-8.73K-3.02%359.00K
VANGUARD FIDUCIARY TRUST CO225.30K89.76K+66.23%288.39K
NORTHERN TRUST CORP61.53K19.69K+47.05%78.76K
STATE STREET CORP58.60K00.00%75.01K
BANK OF NEW YORK MELLON CORP51.45K00.00%65.86K
CAPTRUST FINANCIAL ADVISORS51.19K51.19KNew65.53K
OSAIC HOLDINGS, INC.41.49K5.70K+15.91%53.11K
WORLD INVESTMENT ADVISORS37.04K00.00%48.15K
ONEDIGITAL INVESTMENT ADVISORS LLC23.00K00.00%29.44K
QUBE RESEARCH & TECHNOLOGIES LTD21.79K21.79KNew27.89K
PRAETORIAN WEALTH MANAGEMENT, INC.20.00K00.00%25.60K
VIRTU FINANCIAL LLC17.55K17.55KNew22.00K
VESTMARK ADVISORY SOLUTIONS, INC.13.60K500+3.82%17.41K
CITADEL ADVISORS LLC13.27K13.27KNew16.98K
MORTON CAPITAL MANAGEMENT LLC/CA12.66K00.00%16.20K
TWO SIGMA SECURITIES, LLC12.62K12.62KNew16.15K
CLEARSTEAD ADVISORS, LLC12.53K00.00%16.04K
NORTHCREST ASSET MANANGEMENT, LLC12.12K12.12KNew15.39K
KESTRA PRIVATE WEALTH SERVICES, LLC11.00K00.00%14.08K
REGIONS FINANCIAL CORP10.64K00.00%13.62K
UBS GROUP AG7.96K-1.25K-13.61%10.19K
TOWER RESEARCH CAPITAL LLC (TRC)7.92K7.92KNew10.14K
VANGUARD GLOBAL ADVISERS, LLC6.55K00.00%8.39K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Telomir Pharmaceuticals (TELO) Stock Insights

TELO$0.99-0.03 -2.75%

$73.03M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History